S
SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
TWSE:4119
Price:
52.8
TWD
-2.58%
Market Closed
Market Cap:
NT$6.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SCI Pharmtech Inc
Total Current Assets
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
SCI Pharmtech Inc
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Total Current Assets
NT$1.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Total Current Assets
NT$6.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Total Current Assets
NT$5.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Total Current Assets
NT$16.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
23%
|
CAGR 10-Years
14%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Total Current Assets
NT$5.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
C
|
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
|
Total Current Assets
NT$9.7B
|
CAGR 3-Years
152%
|
CAGR 5-Years
202%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
Intrinsic Value
37.24
TWD
Overvaluation 29%
S
See Also
What is SCI Pharmtech Inc's Total Current Assets?
Total Current Assets
1.1B
TWD
1.1B
TWD
Based on the financial report for Sep 30, 2025, SCI Pharmtech Inc's Total Current Assets amounts to 1.1B TWD.
What is SCI Pharmtech Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
-3%
-3%
Over the last year, the Total Current Assets growth was -50%.
